6-K (Current report)
- Feb 19
- 1 min read
Title: 6-K (Current report) | Filled Date: 2026-02-19 | Entity Name: Intercure Ltd. (INCR)
6-K 1 form6-k.htm 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of February 2026
Commission File Number: 001-40614
INTERCURE LTD.
(Translation of registrant's name into English)
85 Medinat ha-Yehudim Street
Herzliya, 4676670, Israel
Tel: +972 77 460 5012
(Address of principal executive offices)
On February 19, 2026, InterCure Ltd. (the “Registrant”) issued a press release titled “InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million,” a copy of which is furnished as Exhibit 99.1 with this report of Foreign Private Issuer on Form 6-K.
Exhibit No. | Description |
99.1 | Press Release issued by InterCure Ltd. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
INTERCURE LTD.
Date: February 19, 2026 /s/ Amos Cohen
Amos Cohen
Chief Financial Officer
